EpCAM-Expressing Circulating Tumor Cells in Colorectal Cancer
暂无分享,去创建一个
S. Ceccarelli | C. Nicolazzo | C. Raimondi | F. Francescangeli | P. Trenta | V. Magri | C. Marchese | A. Zeuner | A. Gradilone | P. Gazzaniga | Federica Francescangeli
[1] L. Terracciano,et al. Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer , 2016, International journal of cancer.
[2] Leon W M M Terstappen,et al. Capture of Tumor Cells on Anti-EpCAM-Functionalized Poly(acrylic acid)-Coated Surfaces. , 2016, ACS applied materials & interfaces.
[3] K. Pantel,et al. Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest® , 2016, PloS one.
[4] R. Salgado,et al. Evaluation and consequences of heterogeneity in the circulating tumor cell compartment , 2016, Oncotarget.
[5] Leon W M M Terstappen,et al. Challenges in circulating tumor cell detection by the CellSearch system , 2016, Molecular oncology.
[6] C. Nicolazzo,et al. Circulating tumor cells isolation: the "post-EpCAM era". , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[7] Yan Zhang,et al. Capturing Cancer: Emerging Microfluidic Technologies for the Capture and Characterization of Circulating Tumor Cells. , 2015, Small.
[8] E. Cortesi,et al. The rationale for liquid biopsy in colorectal cancer: a focus on circulating tumor cells , 2015, Expert review of molecular diagnostics.
[9] G. Járvás,et al. Computational fluid dynamics-based design of a microfabricated cell capture device. , 2015, Journal of chromatographic science.
[10] N. Stoecklein,et al. Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences , 2014, Cellular and Molecular Life Sciences.
[11] T. Price,et al. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] K. Pantel,et al. Challenges in circulating tumour cell research , 2014, Nature Reviews Cancer.
[13] B. Giepmans,et al. EpCAM: structure and function in health and disease. , 2013, Biochimica et biophysica acta.
[14] Chunsheng Jiang,et al. Microfluidics and circulating tumor cells. , 2013, The Journal of molecular diagnostics : JMD.
[15] A. Farcomeni,et al. Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] L. Frati,et al. Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[17] M. Koch,et al. Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies , 2010, BMC biotechnology.
[18] Cinzia Marchese,et al. The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold. , 2008, Biomaterials.
[19] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[20] G. Fleuren,et al. Epidermal Growth Factor-Like Repeats Mediate Lateral and Reciprocal Interactions of Ep-CAM Molecules in Homophilic Adhesions , 2001, Molecular and Cellular Biology.
[21] M Aizawa,et al. Assembling of engineered IgG-binding protein on gold surface for highly oriented antibody immobilization. , 2000, Journal of biotechnology.